Company intelligence / Profile preview

Max Biocare

South Yarra, Victoria, Australiamaxbiocare.com ↗
Ownership
Private
Employees
~53
Development stage
Commercial
01

Overview

Max Biocare develops and markets scientifically validated natural medicines, nutraceuticals, and wellness products. All therapeutic formulas are regulated by the Australian Therapeutic Goods Administration (TGA) and manufactured under GMP standards. The company has over two decades of experience as an international innovator in bioscience and healthcare. No clinical trial results or prescription pharmaceuticals are reported.

Therapeutic areas
Other
Modalities
Small moleculeProteinNon-pharmacological therapy
Industry
Food & Nutrition
02

Drug pipeline

1 asset

Maxucosa

Commercial
Indications
Immune health, Skin health, Inflammation

Beyond the preview

Go deeper on Max Biocare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Max Biocare.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call